Viewing Study NCT06539663



Ignite Creation Date: 2024-10-26 @ 3:37 PM
Last Modification Date: 2024-10-26 @ 3:37 PM
Study NCT ID: NCT06539663
Status: COMPLETED
Last Update Posted: None
First Post: 2024-07-30

Brief Title: The Role of OmniLenz in the Treatment of Small Corneal Perforations Secondary to Exposure Keratitis in ICU Patients
Sponsor: None
Organization: None

Study Overview

Official Title: The Role of OmniLenz in the Treatment of Small Corneal Perforations Secondary to Exposure Keratitis in ICU Patients
Status: COMPLETED
Status Verified Date: 2024-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Case series of 5 ICU patients in Farwaniya Hospital who developed exposure keratitis and a subsequent small corneal perforation between April 2022 and April 2024

The investigators highlight the non-surgical role of OmniLenz in the treatment of small corneal perforations secondary to exposure keratitis The inclusion criteria were corneal perforation less than 1mm in size positive culture sensitivity results and showing initial improvement on topical antibiotic eye drops
Detailed Description: The primary outcome measures were healing of the corneal perforation a negative Seidel test and reformation of the anterior chamber

Secondary outcome measures were improvement of all three of ciliary injection state of epithelial defect and corneal infiltration

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None